Log In
BCIQ
Print this Print this
 

PTT256 mAb

  Manage Alerts
Collapse Summary General Information
Company Pro-Cure Therapeutics Ltd.
DescriptionHumanized mAb that targets PTT256
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationProstate cancer
Indication DetailsTreat prostate cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today